FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298127711> ?p ?o ?g. }

• W4298127711 endingPage "166" @default.
• W4298127711 startingPage "148" @default.
• W4298127711 abstract "Anticoagulants are promising regimens for treating coronavirus disease 2019 (COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is optimal remains under active discussion.We comprehensively searched PubMed, Embase, Scopus, Web of Science, Cochrane Library, ClinicalTrials, and MedRxiv databases on April 26, 2022. Two independent researchers conducted literature selection and data extraction separately according to predetermined criteria. Notably, this is the first meta-analysis on COVID-19, taking serious consideration regarding the dosage overlap between the 2 comparison groups of prophylactic anticoagulation (PA) and intermediate-to-therapeutic anticoagulation (I-TA).We included 11 randomized controlled trials (RCTs) and 36 cohort studies with 27,051 COVID-19 patients. By analyzing all the RCTs, there was no significant difference in mortality between the PA and I-TA groups, which was further confirmed by trial sequential analysis (TSA) (odds ratio [OR]: 0.93; 95% confidence interval [CI]: 0.71-1.22; P = 0.61; TSA adjusted CI: 0.71-1.26). The rate of major bleeding was remarkably higher in the I-TA group than in the PA group, despite adjusting for TSA (OR: 1.73; 95% CI: 1.15-2.60; P = 0.009; TSA adjusted CI: 1.09-2.58). RCTs have supported the beneficial effect of I-TA in reducing thrombotic events. After including all studies, mortality in the I-TA group was significantly higher than in the PA group (OR: 1.38; 95% CI: 1.15-1.66; P = 0.0005). The rate of major bleeding was similar to the analysis from RCTs (OR: 2.24; 95% CI: 1.86-2.69; P < 0.00001). There was no distinct difference in the rate of thrombotic events between the 2 regimen groups. In addition, in both critical and noncritical subgroups, I-TA failed to reduce mortality but increased major bleeding rate compared with PA, as shown in meta-analysis of all studies, as well as RCTs only. Meta-regression of all studies suggested that there was no relationship between the treatment effect and the overall risk of mortality or major bleeding (P = 0.14, P = 0.09, respectively).I-TA is not superior to PA for treating COVID-19 because it fails to lower the mortality rate but increases the major bleeding rate in both critical and noncritical patients." @default.
• W4298127711 created "2022-10-01" @default.
• W4298127711 creator A5015937552 @default.
• W4298127711 creator A5027579505 @default.
• W4298127711 creator A5034085664 @default.
• W4298127711 creator A5037227682 @default.
• W4298127711 creator A5040295662 @default.
• W4298127711 creator A5041773009 @default.
• W4298127711 creator A5042332666 @default.
• W4298127711 creator A5048573040 @default.
• W4298127711 creator A5059013718 @default.
• W4298127711 creator A5059788513 @default.
• W4298127711 creator A5062572385 @default.
• W4298127711 creator A5064481096 @default.
• W4298127711 creator A5072080969 @default.
• W4298127711 creator A5074200042 @default.
• W4298127711 creator A5081077592 @default.
• W4298127711 creator A5084329036 @default.
• W4298127711 creator A5090692502 @default.
• W4298127711 creator A5091904451 @default.
• W4298127711 date "2022-09-01" @default.
• W4298127711 modified "2023-10-14" @default.
• W4298127711 title "The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants" @default.
• W4298127711 cites W2151353824 @default.
• W4298127711 cites W2165010366 @default.
• W4298127711 cites W2170984368 @default.
• W4298127711 cites W2894506942 @default.
• W4298127711 cites W3001118548 @default.
• W4298127711 cites W3008461878 @default.
• W4298127711 cites W3008827533 @default.
• W4298127711 cites W3009885589 @default.
• W4298127711 cites W3014571869 @default.
• W4298127711 cites W3015218828 @default.
• W4298127711 cites W3015863623 @default.
• W4298127711 cites W3028989873 @default.
• W4298127711 cites W3044053647 @default.
• W4298127711 cites W3080563234 @default.
• W4298127711 cites W3080671425 @default.
• W4298127711 cites W3081515108 @default.
• W4298127711 cites W3087060799 @default.
• W4298127711 cites W3087308906 @default.
• W4298127711 cites W3087656790 @default.
• W4298127711 cites W3088719217 @default.
• W4298127711 cites W3089370525 @default.
• W4298127711 cites W3092252175 @default.
• W4298127711 cites W3092403893 @default.
• W4298127711 cites W3092984699 @default.
• W4298127711 cites W3093543795 @default.
• W4298127711 cites W3096414087 @default.
• W4298127711 cites W3097754889 @default.
• W4298127711 cites W3108597594 @default.
• W4298127711 cites W3109578812 @default.
• W4298127711 cites W3110977870 @default.
• W4298127711 cites W3111740979 @default.
• W4298127711 cites W3118615836 @default.
• W4298127711 cites W3120028189 @default.
• W4298127711 cites W3120321871 @default.
• W4298127711 cites W3122174631 @default.
• W4298127711 cites W3123463087 @default.
• W4298127711 cites W3126678596 @default.
• W4298127711 cites W3131028610 @default.
• W4298127711 cites W3135868073 @default.
• W4298127711 cites W3136016654 @default.
• W4298127711 cites W3138214175 @default.
• W4298127711 cites W3152944454 @default.
• W4298127711 cites W3153748994 @default.
• W4298127711 cites W3155086307 @default.
• W4298127711 cites W3156466542 @default.
• W4298127711 cites W3157304674 @default.
• W4298127711 cites W3158138914 @default.
• W4298127711 cites W3169953297 @default.
• W4298127711 cites W3172155398 @default.
• W4298127711 cites W3172283028 @default.
• W4298127711 cites W3174930042 @default.
• W4298127711 cites W3180828297 @default.
• W4298127711 cites W3182289923 @default.
• W4298127711 cites W3189008560 @default.
• W4298127711 cites W3194544920 @default.
• W4298127711 cites W3196915776 @default.
• W4298127711 cites W3197505420 @default.
• W4298127711 cites W3197972104 @default.
• W4298127711 cites W3201251239 @default.
• W4298127711 cites W3201313619 @default.
• W4298127711 cites W3202150016 @default.
• W4298127711 cites W3202229605 @default.
• W4298127711 cites W3203603084 @default.
• W4298127711 cites W3205091111 @default.
• W4298127711 cites W3205387447 @default.
• W4298127711 cites W3207102924 @default.
• W4298127711 cites W4200012048 @default.
• W4298127711 cites W4200557111 @default.
• W4298127711 cites W4205231802 @default.
• W4298127711 cites W4205922819 @default.
• W4298127711 cites W4206690947 @default.
• W4298127711 cites W4210827484 @default.
• W4298127711 cites W4212763142 @default.
• W4298127711 cites W4225862376 @default.
• W4298127711 cites W4226092088 @default.

• next